Correction: Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation.
Cancer Imaging
; 24(1): 82, 2024 Jul 01.
Article
in En
| MEDLINE
| ID: mdl-38951928
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Cancer Imaging
Journal subject:
DIAGNOSTICO POR IMAGEM
/
NEOPLASIAS
Year:
2024
Document type:
Article
Affiliation country:
Alemania
Country of publication:
Reino Unido